Including insulin in parenteral mixed solutions presents challenges in effectively controlling insulin infusion rates owing to drug interactions or precipitation, resulting in significant fluctuations in blood sugar levels and an increased risk of hypoglycemia. Here, INS is linked to Hypoglycemia.